Biological Chemistry

Issue: Jun 2005

Volume 386, Number 6

Assembly of natural and recombinant prion protein into fibrils

Karl-Werner Leffers,

1. Institut für Physikalische Biologie und Biologisch-Medizinisches Forschungszentrum, Heinrich-Heine-Universität Düsseldorf, D-40225 Düsseldorf, Germany

1
Holger Wille,

2. Institute for Neurodegenerative Diseases and Department of Neurology, University of California San Francisco, San Francisco, CA 94143, USA

2
Jan Stöhr,

3. Institut für Physikalische Biologie und Biologisch-Medizinisches Forschungszentrum, Heinrich-Heine-Universität Düsseldorf, D-40225 Düsseldorf, Germany

3
Erika Junger,

4. Deutsches Diabetesforschungsinstitut Düsseldorf, D-40225 Düsseldorf, Germany

4
Stanley B. Prusiner,

5. Institute for Neurodegenerative Diseases, Department of Neurology and Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA 94143, USA

5
Detlev Riesner

6. Institut für Physikalische Biologie und Biologisch-Medizinisches Forschungszentrum, Heinrich-Heine-Universität Düsseldorf, D-40225 Düsseldorf, Germany

6
Corresponding author
Citation Information. Biological Chemistry. Volume 386, Issue 6, Pages 569–580, ISSN (Online) 1437-4315, ISSN (Print) 1431-6730, DOI: 10.1515/BC.2005.067, June 2005
Publication History: Received: //; accepted: //; published online: 07/07/2005

Abstract

The conversion of the α-helical, cellular isoform of the prion protein (PrPC) to the insoluble, β-sheet-rich, infectious, disease-causing isoform (PrPSc) is the fundamental event in the prion diseases. The C-terminal fragment of PrPSc (PrP 27–30) is formed by limited proteolysis and retains infectivity. Unlike full-length PrPSc, PrP 27–30 polymerizes into rod-shaped structures with the ultra-structural and tinctorial properties of amyloid. To study the folding of PrP, both with respect to the formation of PrPSc from PrPC and the assembly of rods from PrP 27–30, we solubilized Syrian hamster (sol SHa) PrP 27–30 in low concentrations (0.2%) of sodium dodecyl sulfate (SDS) under conditions previously used to study the structural transitions of this protein. Sol SHaPrP 27–30 adopted a β-sheet-rich structure at SDS concentrations between 0.02% and 0.04% and remained soluble. Here we report that NaCl stabilizes SHaPrP 27–30 in a soluble, β-sheet-rich state that allows fibril assembly to proceed over several weeks. Under these conditions, fibril formation occurred not only with sol PrP 27–30, but also with native SHaPrPC. Addition of sphingolipids seems to increase fibril growth. When recombinant (rec) SHaPrP(90–231) was exposed to low concentrations of SDS, similar to those used to polymerize sol SHaPrP 27–30 in the presence of 250 mM NaCl, fibril formation occurred regularly. When fibrils formed from PrP 27–30 or PrPC were bioassayed in transgenic mice overexpressing full-length SHaPrP, no infectivity was obtained, whereas amyloid fibrils formed of rec mouse PrP(89–230) were infectious. At present, it cannot be determined whether the lack of infectivity is caused by a difference in the structure of the fibrils or in the bioassay conditions.

Keywords α-helix, amyloid, β-sheet transition states, cellular prion protein (PrP), sodium dodecylsulfate

Citing Articles

Show All Citing Articles